Manejo inicial del diagnóstico y tratamiento | 15 NOV 21

Convulsiones en adultos

Una convulsión puede afectar sustancialmente las interacciones sociales, el empleo y la elegibilidad para conducir de una persona
Autor/a: Phil E.M. Smith Fuente: Initial Management of Seizure in Adults N Engl J Med 2021;385:251-63
INDICE:  1. Texto principal | 2. Referencias bibliográficas
Referencias bibliográficas

1. Hauser WA, Beghi E. First seizure definitions and worldwide incidence and mortality. Epilepsia 2008; 49: Suppl 1: 8-12.

2. Krumholz A, Wiebe S, Gronseth GS, et al. Evidence-based guideline: management of an unprovoked first seizure in adults: report of the guideline development subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2015; 84: 1705-13.

3. Fiest KM, Sauro KM, Wiebe S, et al. Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology 2017; 88: 296-303.

4. Fisher RS, Acevedo C, Arzimanoglou A, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia 2014; 55: 475-82.

5. Kim LG, Johnson TL, Marson AG, Chadwick DW. Prediction of risk of seizure recurrence after a single seizure and early epilepsy: further results from the MESS trial. Lancet Neurol 2006; 5: 317-22.

6. Jones S, Pahl C, Trinka E, Nashef L. A protocol for the inhospital emergency drug management of convulsive status epilepticus in adults. Pract Neurol 2014; 14: 194-7.

7. Derry CP. Sleeping in fits and starts: a practical guide to distinguishing nocturnal epilepsy from sleep disorders. Pract Neurol 2014; 14: 391-8.

8. Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 522-30.

9. Scheffer IE, Berkovic S,  Capovilla G, et al. ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology. Epilepsia 2017; 58: 512-21.

10. Brugada P, Geelen P. Some electrocardiographic patterns predicting sudden cardiac death that every doctor should recognize. Acta Cardiol 1997; 52: 473-84.

11. Duncan JS. Brain imaging in epilepsy. Pract Neurol 2019; 19: 438-43.

12. Collins S, Iansek R. A prospective study of the predictive value of electroencephalographic abnormalities for epileptic loss of consciousness. Clin  Exp Neurol1988; 25: 103-8.

13. Hauser WA, Rich SS, Annegers JF, Anderson VE. Seizure recurrence after a 1st unprovoked seizure: an extended followup. Neurology 1990; 40: 1163-70.

14. King MA, Newton MR, Jackson GD, et al. Epileptology of the first-seizure presentation: a clinical, electroencephalographic, and magnetic resonance imaging study of 300 consecutive patients. Lancet 1998; 352: 1007-11.

15. Geut I, Weenink S, Knottnerus ILH, van Putten MJAM. Detecting interictal discharges in first seizure patients: ambulatory EEG or EEG after sleep deprivation? Seizure 2017; 51: 52-4.

16. Koutroumanidis M, Bruno E. Epileptology of the first tonic-clonic seizure in adults and prediction of seizure recurrence. Epileptic Disord 2018; 20: 490-501.

17. Marson AG, Al-Kharusi AM,  lwaidh

M, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007; 369: 1000-15.

18. Marson A, Burnside G, Appleton R, et al. The SANAD II study of the effectiveness and cost-effectiveness of levetiracetam, zonisamide, or lamotrigine for newly diagnosed focal epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021; 397: 1363-74.

19. Mani R, Monteleone C, Schalock PC, Truong T, Zhang XB, Wagner ML. Rashes and other hypersensitivity reactions associated with antiepileptic drugs: a review of current literature. Seizure 2019; 71: 270-8.

20. Brodie MJ, Perucca E, Ryvlin P, Ben- Menachem E, Meencke HJ; Levetiracetam Monotherapy Study Group. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy. Neurology 2007; 68: 402-8.

21. Marson A, Burnside G, Appleton R, et al. The SANAD II study of the effectiveness and cost-effectiveness of valproate versus levetiracetam for newly diagnosed generalised and unclassifiable epilepsy: an open-label, non-inferiority, multicentre, phase 4, randomised controlled trial. Lancet 2021; 397: 1375-86.

 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

Contenidos relacionados
Los editores le recomiendan continuar con las siguientes lecturas:
AAIP RNBD
Términos y condiciones de uso | Todos los derechos reservados | Copyright 1997-2021